Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment.
Karadsheh
N S
NS
Shaker
Q
Q
Ratroat
B
B
D000328:Adult; D000075202:Contraindications; D003579:Cytochrome Reductases / Q000097:blood / Q000172:deficiency*; D042966:Cytochrome-B(5) Reductase; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000150:complications*; D006801:Humans; D007597:Jordan; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000188:drug therapy; D008751:Methylene Blue / Q000008:administration & dosage; D008787:Metoclopramide / Q000008:administration & dosage / Q000009:adverse effects*; D017211:Treatment Failure
D018492:Dopamine Antagonists; D003579:Cytochrome Reductases; D042966:Cytochrome-B(5) Reductase; D008787:Metoclopramide; D008751:Methylene Blue